Aptar Names Pharma Head Touya as Next CEO After 2025 Sales Climb 5%
AptarGroup shareholders approved all ballot items as the packaging firm reported $3.8 billion in 2025 sales and outlined CEO succession. AptarGroup announced CEO Stephan Tanda will retire on September 1, 2026, with Gael Touya, current head of Aptar Pharma, succeeding him.